MAP2K5 and cancer: While MEK5 or ERK5 mutations are rare in cancer, these components are sometimes over-expressed; indeed, MAPK7 is amplified in hepatocellular carcinoma (HCC)24, although it appears not to drive HCC cell proliferation25.